Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Accumulated Depreciation (2020 - 2022)

Historic Accumulated Depreciation for Cullinan Therapeutics (CGEM) over the last 3 years, with Q4 2022 value amounting to $135000.0.

  • Cullinan Therapeutics' Accumulated Depreciation fell 4181.03% to $135000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $135000.0, marking a year-over-year decrease of 4181.03%. This contributed to the annual value of $135000.0 for FY2022, which is 4181.03% down from last year.
  • As of Q4 2022, Cullinan Therapeutics' Accumulated Depreciation stood at $135000.0, which was down 4181.03% from $232000.0 recorded in Q4 2021.
  • Cullinan Therapeutics' Accumulated Depreciation's 5-year high stood at $232000.0 during Q4 2021, with a 5-year trough of $135000.0 in Q4 2022.
  • Over the past 3 years, Cullinan Therapeutics' median Accumulated Depreciation value was $179000.0 (recorded in 2020), while the average stood at $182000.0.
  • As far as peak fluctuations go, Cullinan Therapeutics' Accumulated Depreciation surged by 2960.89% in 2021, and later tumbled by 4181.03% in 2022.
  • Over the past 3 years, Cullinan Therapeutics' Accumulated Depreciation (Quarter) stood at $179000.0 in 2020, then increased by 29.61% to $232000.0 in 2021, then plummeted by 41.81% to $135000.0 in 2022.
  • Its Accumulated Depreciation stands at $135000.0 for Q4 2022, versus $232000.0 for Q4 2021 and $179000.0 for Q4 2020.